Fractyl Health Receives Nasdaq Minimum Bid Price Notice

Fractyl Health, Inc. ( (GUTS) ) has issued an update.

On March 13, 2026, Fractyl Health, Inc. was notified by Nasdaq that its common stock had fallen out of compliance with the Nasdaq Global Market’s $1.00 minimum bid price rule after trading below that threshold for 30 consecutive business days. The company has 180 calendar days, until Sept. 9, 2026, to restore compliance by achieving a minimum bid price of at least $1.00 for 10 consecutive business days, and the notice does not immediately affect the current listing of its shares.

If Fractyl fails to regain compliance by that deadline, it may seek an additional compliance period by applying to transfer its listing to the Nasdaq Capital Market, paying an application fee, and satisfying other listing standards, potentially including a reverse stock split to cure the price deficiency. Should Nasdaq determine that Fractyl cannot reasonably cure the issue, or if the company does not pursue a transfer or other remedies, its shares would face potential delisting, although the company would retain the right to appeal and says it will actively monitor its share price and consider available options to preserve its listing.

The most recent analyst rating on (GUTS) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Fractyl Health, Inc. stock, see the GUTS Stock Forecast page.

Spark’s Take on GUTS Stock

According to Spark, TipRanks’ AI Analyst, GUTS is a Neutral.

The score is held down primarily by very weak financial performance (minimal/declining revenue, large ongoing losses, heavy cash burn, and slightly negative equity). Technicals also lean bearish (below short-term moving averages with weak RSI/MACD). Offsetting these, earnings-call commentary was relatively positive due to encouraging clinical results, strong cash position/runway into early 2027, and clear 2026 milestones, but it is not enough to overcome current financial and momentum risks.

To see Spark’s full report on GUTS stock, click here.

More about Fractyl Health, Inc.

Fractyl Health, Inc. is a publicly traded company listed on the Nasdaq Global Market. The firm’s common stock is subject to Nasdaq’s continued listing standards, including the minimum bid price requirement, which is critical to maintaining its presence on this major U.S. exchange and access to related capital markets and investor visibility.

Average Trading Volume: 5,775,203

Technical Sentiment Signal: Sell

Current Market Cap: $63.05M

For an in-depth examination of GUTS stock, go to TipRanks’ Overview page.